Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Greer

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The American Journal of Medicine|August 1, 1986
Lymphocyte-depleted Hodgkin's disease. Clinicopathologic review of 25 patientsJ P Greer, M C Kinney, J B Cousar, et al.
Bone Marrow Transplantation|March 30, 2001
Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic studyS N Wolff, R Herzig, J Lynch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcomeA F List, J P Greer, J C Cousar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Bone Marrow Transplantation|April 10, 2012
Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteriaR Jacobs, U Tran, H Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's diseaseD E Reece, M J Barnett, J M Connors, et al.
Bone Marrow Transplantation|June 26, 2010
Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomesB G Engelhardt, M Jagasia, B N Savani, et al.
Blood|March 15, 1996
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemiaA F List, C S Spier, T M Grogan, et al.
Leukemia & Lymphoma|October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant GroupD R Fleming, S N Wolff, J W Fay, et al.
Bone Marrow Transplantation|April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemiaZ S Pavletic, E R Arrowsmith, P J Bierman, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The American Journal of Medicine|August 1, 1986
Lymphocyte-depleted Hodgkin's disease. Clinicopathologic review of 25 patientsJ P Greer, M C Kinney, J B Cousar, et al.
Bone Marrow Transplantation|March 30, 2001
Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic studyS N Wolff, R Herzig, J Lynch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcomeA F List, J P Greer, J C Cousar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Bone Marrow Transplantation|April 10, 2012
Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteriaR Jacobs, U Tran, H Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's diseaseD E Reece, M J Barnett, J M Connors, et al.
Bone Marrow Transplantation|June 26, 2010
Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomesB G Engelhardt, M Jagasia, B N Savani, et al.
Blood|March 15, 1996
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemiaA F List, C S Spier, T M Grogan, et al.
Leukemia & Lymphoma|October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant GroupD R Fleming, S N Wolff, J W Fay, et al.
Bone Marrow Transplantation|April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemiaZ S Pavletic, E R Arrowsmith, P J Bierman, et al.
Pageof 9